Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115)
- 31 December 2022
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 198 (1) , 123-130
Abstract
Purpose Breast cancer (BC) is the most common type of cancer among women in Brazil. Evidence shows that delayed treatment onset is associated with increased mortality. This study aimed to evaluate median days between diagnosis and treatment and factors associated with delayed start of treatment (> 60 days after diagnosis): stage, treatment received, subtype, epidemiological characteristics, and type of healthcare coverage. Methods This analysis included 1709 stage I–III BC patients from AMAZONA III, a prospective, observational study, diagnosed from January 2016 to March 2018 in 22 centers in Brazil. Results The median number of days from diagnosis to beginning of first oncologic treatment was 46 days (IQR 28–75) overall, 43 days (IQR 25–75) for stage I disease, 49 days (IQR 28–81) for stage II, and 44 days (IQR 30–68) for stage III, (p = 0.1180). According to first treatment received, diagnosis-to-treatment interval was 43 days (IQR 29–65) for neoadjuvant chemotherapy and 48 days (IQR 26–81) for surgery. Diagnosis-to-treatment interval was higher in women treated in the public system versus the private system (56 vs. 34 days, p < 0.0001). Patients in the public system had an increased odds of delayed treatment initiation (OR 4.74 95% CI 3.09–7.26, p < .0001). The longer interval from diagnosis to treatment in the public system was independent of clinical stage, type of treatment (systemic vs surgery first), subtype and region of the country. Conclusion By characterizing the delays in care delivery, our study will aid stakeholders to better design interventions and allocate resource to improve timely treatment for breast cancer in Brazil. ClinicalTrials.gov Identifier: NCT02663973, registered on January, 26th, 2016.Keywords
Funding Information
- Programa Nacional de Apoio à Atenção Oncológica (25000.173.901/2013–73)
This publication has 22 references indexed in Scilit:
- Posttraumatic stress disorder symptoms in newly diagnosed patients with head and neck cancer and their partnersHead & Neck, 2014
- Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast CancerJournal of Clinical Oncology, 2014
- Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2014
- Time to Begin Adjuvant Chemotherapy and Survival in Breast Cancer Patients: A Retrospective Observational Study Using Latent Class AnalysisThe Breast Journal, 2013
- Impact of Surgery-Radiation Interval on Locoregional Outcome in Patients Receiving Neo-adjuvant Therapy and MastectomyThe Breast Journal, 2013
- Planning cancer control in Latin America and the CaribbeanThe Lancet Oncology, 2013
- Delay to Curative Surgery Greater than 12 Weeks Is Associated with Increased Mortality in Patients with Colorectal and Breast Cancer but Not Lung or Thyroid CancerAnnals of Surgical Oncology, 2013
- Effect on Survival of Longer Intervals Between Confirmed Diagnosis and Treatment Initiation Among Low-Income Women With Breast CancerJournal of Clinical Oncology, 2012
- Breast cancer in Brazil: present status and future goalsThe Lancet Oncology, 2012
- Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: a nationwide Danish studyQuality of Life Research, 2011